We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
-16.55%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$143B
AUM Growth
-$39.6B
Cap. Flow
-$3.41B
Cap. Flow %
-2.39%
Top 10 Hldgs %
39.86%
Holding
510
New
11
Increased
135
Reduced
148
Closed
12

Top Buys

Rank Stock Value
1
SE icon
Sea Limited
SE
+$1.03B
2
CPNG icon
Coupang
CPNG
+$978M
3
RBLX icon
Roblox
RBLX
+$473M
4
ADI icon
Analog Devices
ADI
+$303M
5
DNA icon
Ginkgo Bioworks
DNA
+$284M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$921M
2
BABA icon
Alibaba
BABA
+$476M
3
PBR icon
Petrobras
PBR
+$417M
4
Z icon
Zillow
Z
+$416M
5
NVDA icon
NVIDIA
NVDA
+$348M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.15%
2 Healthcare 23.85%
3 Technology 18.9%
4 Communication Services 11.36%
5 Financials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUMO
451
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$8K ﹤0.01%
726
DCT
452
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$8K ﹤0.01%
355
MATV icon
453
Mativ Holdings
MATV
$711M
$7K ﹤0.01%
265
NKTR icon
454
Nektar Therapeutics
NKTR
$2.58B
$7K ﹤0.01%
92
OXM icon
455
Oxford Industries
OXM
$552M
$7K ﹤0.01%
73
BMRN icon
456
BioMarin Pharmaceuticals
BMRN
$12.4B
$6K ﹤0.01%
82
CERS icon
457
Cerus
CERS
$474M
$6K ﹤0.01%
1,143
KYNB
458
Kyntra Bio
KYNB
$29.4M
$6K ﹤0.01%
19
NNDM
459
Nano Dimension
NNDM
$343M
$6K ﹤0.01%
1,600
VUZI icon
460
Vuzix
VUZI
$224M
$6K ﹤0.01%
924
NVTA
461
DELISTED
Invitae Corporation
NVTA
$6K ﹤0.01%
800
AGIO icon
462
Agios Pharmaceuticals
AGIO
$1.93B
$5K ﹤0.01%
186
FOLD
463
DELISTED
Amicus Therapeutics
FOLD
$5K ﹤0.01%
538
FVRR icon
464
Fiverr
FVRR
$339M
$5K ﹤0.01%
61
INGN icon
465
Inogen
INGN
$164M
$5K ﹤0.01%
141
MASS icon
466
908 Devices
MASS
$364M
$5K ﹤0.01%
249
PACB icon
467
Pacific Biosciences
PACB
$370M
$5K ﹤0.01%
561
TSVT
468
DELISTED
2seventy bio
TSVT
$5K ﹤0.01%
286
ZD icon
469
Ziff Davis
ZD
$1.98B
$5K ﹤0.01%
53
ONEM
470
DELISTED
1Life Healthcare
ONEM
$5K ﹤0.01%
445
AGX icon
471
Argan
AGX
$8.37B
$4K ﹤0.01%
103
AMRX icon
472
Amneal Pharmaceuticals
AMRX
$5.79B
$4K ﹤0.01%
853
+401
+89% +$1.78K
AXGN icon
473
Axogen
AXGN
$2.5B
$4K ﹤0.01%
444
-250,991
-100% -$2.17M
BLUE
474
DELISTED
bluebird bio
BLUE
$4K ﹤0.01%
43
CGNT icon
475
Cognyte Software
CGNT
$680M
$4K ﹤0.01%
369

Similar funds

Baillie Gifford & Co's Q1 2022 Portfolio in Review

As of Q1 2022, Baillie Gifford & Co held 510 positions worth $143B, down 22% from $182B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q1 2022: portfolio turnover was 4.5%. Baillie Gifford & Co opened 11 new positions and exited 12, leaving the 510-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q1 2022 buy was Roblox: 7,841,669 shares worth $363M.
  • Baillie Gifford & Co added most to Sea Limited in Q1 2022, an estimated $1.03B increase.
  • Baillie Gifford & Co's biggest Q1 2022 reduction was Tesla, cutting an estimated $921M.
  • Baillie Gifford & Co fully exited Stericycle Inc in Q1 2022, selling an estimated $283M.
  • Baillie Gifford & Co's ten largest holdings make up 40% of its $143B portfolio in Q1 2022.
  • Baillie Gifford & Co opened 11 new positions and closed 12 in Q1 2022.
  • Baillie Gifford & Co's portfolio value fell 22% quarter-over-quarter to $143B.

Based on Baillie Gifford & Co's 13F filing for Q1 2022, filed 5 May 2022.